Skip to main content

Ropivacaine Injection

Last Updated: January 25, 2023
Status: Current

Products Affected - Description
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0285-10
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 25 count, NDC 63323-0285-13
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL premixed bag, 1 count, NDC 63323-0285-61
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0285-20
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL premixed bag, 1 count, NDC 63323-0285-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0286-00
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0286-20
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0286-63
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL Steripak plastic ampule, 5 count, NDC 63323-0286-31
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL vial, 25 count, NDC 63323-0286-35
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL vial, 25 count, NDC 63323-0287-21
    • Ropivacaine injection, Akorn, 5 mg/mL, 30 mL vial, 1 count, NDC 17478-0081-30
    • Ropivacaine injection, Baxter, 10 mg/mL, 20 mL vial, 10 count, NDC 43066-0027-10
    • Ropivacaine injection, Baxter, 2 mg/mL, 20 mL vial, 10 count, NDC 43066-0015-10
    • Ropivacaine injection, Baxter, 5 mg/mL, 20 mL vial, 10 count, NDC 43066-0019-10
    • Ropivacaine injection, Baxter, 5 mg/mL, 30 mL vial, 10 count, NDC 43066-0023-10
    • Ropivacaine injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9263-10
    • Ropivacaine injection, Pfizer, 10 mg/mL, 10 mL vial, 10 count, NDC 00409-9303-10 - discontinued
    • Ropivacaine injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-9303-20 - discontinued
    • Ropivacaine injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-9300-10 - discontinued
    • Ropivacaine injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-9300-20 - discontinued
    • Ropivacaine injection, Pfizer, 5 mg/mL, 30 mL vial, 10 count, NDC 00409-9301-30 - discontinued
    • Ropivacaine injection, Pfizer, 7.5 mg/mL, 20 mL vial, 10 count, NDC 00409-9302-20 - discontinued
    • Ropivacaine injection, Sagent, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0652-82
Reason for the Shortage
    • Akorn had ropivacaine on shortage due to increased demand.
    • Baxter has ropivacaine on shortage due to increase demand.
    • Eugia has ropivacaine available.
    • Fresenius Kabi has Naropin on shortage due to increased demand and manufacturing delays.
    • Pfizer discontinued ropivacaine in August 2022.
    • Sagent did not provide a reason for the shortage.
    • Somerset Therapeutics has ropivacaine 5 mg/mL 30 mL vials available.
Available Products
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0288-10
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 25 count, NDC 63323-0288-11
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0288-20
    • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 25 count, NDC 63323-0288-21
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0285-65
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 25 count, NDC 63323-0285-23
    • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0285-64
    • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 25 count, NDC 63323-0286-23
    • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0287-20
    • Ropivacaine injection, Eugia US, 10 mg/mL, 10 mL vial, 25 count, NDC 55150-0200-10
    • Ropivacaine injection, Eugia US, 10 mg/mL, 20 mL vial, 25 count, NDC 55150-0201-20
    • Ropivacaine injection, Eugia US, 2 mg/mL, 100 mL infusion bottle, 25 count, NDC 55150-0196-99
    • Ropivacaine injection, Eugia US, 2 mg/mL, 20 mL vial, 25 count, NDC 55150-0195-20
    • Ropivacaine injection, Eugia US, 5 mg/mL, 20 mL vial, 25 count, NDC 55150-0197-20
    • Ropivacaine injection, Eugia US, 5 mg/mL, 30 mL vial, 25 count, NDC 55150-0198-30
    • Ropivacaine injection, Eugia US, 7.5 mg/mL, 20 mL vial, 25 count, NDC 55150-0199-20
    • Ropivacaine injection, Sagent, 2 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0671-82
    • Ropivacaine injection, Sagent, 2 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0671-87
    • Ropivacaine injection, Sagent, 5 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0652-87
    • Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 10 count, NDC 70069-0062-10
    • Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 25 count, NDC 70069-0062-25
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 1 count, NDC 70069-0064-01
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 10 count, NDC 70069-0064-10
    • Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 25 count, NDC 70069-0064-25

Estimated Resupply Dates

    • Baxter has ropivacaine 2 mg/mL 20 mL vials, 5 mg/mL 20 mL and 30 mL vials, and 10 mg/mL 20 mL vials available limited supply.
    • Fresenius Kabi has Naropin 2 mg/mL 10 mL and 20 mL Steripak ampules on back order and the company cannot estimate a release date. The 2 mg/mL 10 mL vials are on back order and the company estimates a release date of early-March 2023. The 2 mg/mL 100 mL and 200 mL premixed bags are on back order and the company cannot estimate a release date. The 5 mg/mL 30 mL vials are on back order and the company estimates a release date of late-January 2023. The 5 mg/mL 20 mL and 30 mL Steripak ampules are on back order and the company cannot estimate a release date. The 5 mg/mL 200 mL bottles are on back order and the company estimates a release date of late-January 2023. The 7.5 mg/mL 20 mL vials are on back order and the company estimates a release date of late-February 2023. The 10 mg/mL 20 mL Steripak ampules are on back order and the company cannot estimate a release date.
    • Hikma has ropivacaine 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date.
    • Sagent has ropivacaine 5 mg/mL 100 mL premixed bags on allocation.

Updated

Updated January 25, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.